RxDoctor Payments Data

Christina Booker, MD

Family Medicine · West Union, SCNPI 1205993466

Payments from drug & device makers

$8,435in general payments, 2019–2025

Across 591 payments — averaging $14.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Novo Nordisk$1K
  • AstraZeneca$660
  • Lilly USA, LLC$615
  • GSK$501
  • Amgen$385
  • plus $4K from 39 others

What the payments were for

  • Food & beverage$8,34799%
  • Education$871%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$8,435 in reported general payments places this provider in the 90th percentile of 2,153 family medicine providers in South Carolina.

See all family medicine providers in South Carolina

Medicare billing

Part B allowed, 2024
$102,530
Medicare patients
314
Services billed
1,723

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide62$67,968
EliquisApixaban66$67,740
MounjaroTirzepatide48$54,099
JardianceEmpagliflozin44$38,884
Synjardy XrEmpagliflozin/Metformin Hcl32$38,821
Trelegy ElliptaFluticasone/Umeclidin/Vilanter28$30,216
VraylarCariprazine Hcl19$26,585
RybelsusSemaglutide14$22,830
FarxigaDapagliflozin Propanediol17$17,603
LinzessLinaclotide20$16,261
Fiasp FlextouchInsulin Aspart (Niacinamide)16$11,202
Rosuvastatin Calcium199$5,270
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen185$4,880
Solifenacin Succinate26$2,989
Levothyroxine Sodium241$2,680

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$1,108$90,79876 claims
Boehringer IngelheimJardiance, Synjardy Xr$54$77,70576 claims
PfizerEliquis$201$67,74066 claims
Lilly USA, LLCMounjaro$615$54,09948 claims
AbbVieVraylar, Linzess$1,428$42,84639 claims
GSKTrelegy Ellipta$501$30,21628 claims
AstraZenecaFarxiga$660$17,60317 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,153 family medicine providers in South Carolina.

Other family medicine in West Union

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →